ArticleMedicine2026
Trends in multimorbidity among US adults and the correlation between physical activity and mortality: Prospective cohort study from 1999 to 2018.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Evidence regarding the mortality risk associated with physical activity (PA) and multimorbidity is limited. This study investigates trends in the prevalence of multimorbidity in the population and the mortality risk associated with PA and multimorbidity. The association between PA and overall survival was analyzed in 39,940 subjects from the National Health and Nutrition Examination Survey cohorts. Among the 39,940 participants (weighted average age: 46.84; 50.86% female), the age-standardized prevalence of multimorbidity rose significantly, from 15.87% (95% confidence interval [CI] = 14.86%-16.87%) in 1999 to 2000 to 19.96% (95% CI = 17.61%-22.32%) in 2017 to 2018. The population's multimorbidity detection rate was 25.22%. The all-cause mortality risks for multimorbidity were: dual-multimorbidity (hazard ratio [HR] = 1.97, 95% CI = 1.76-2.20), triple-multimorbidity (HR = 2.69, 95% CI = 2.35-3.08), quadruple-multimorbidity (HR = 3.22, 95% CI = 2.59-3.99). "Diabetes mellitus + cardiovascular disease + respiratory diseases" had the highest mortality risk (HR = 4.37, 95% CI = 2.67-7.16). PA reduced all-cause and cause-specific mortality, with moderate-intensity PA lowering all-cause mortality by 22% compared to low-intensity PA, and high-intensity PA by 6% compared to moderate-intensity PA. Multimorbidity led to a 5.64 years life expectancy loss, while PA could recover up to 2.31 years. PA potentially recouped 2.96 and 2.19 years of life lost due to comorbidity in females and males, respectively. According to National Health and Nutrition Examination Survey data from 1999 to 2000 to 2017 to 2018, multimorbidity prevalence increased. PA reduces all-cause mortality by 32%. Greater PA intensity correlates with more significant mortality reduction. Multimorbidity cuts life expectancy by 5.64 years, recoverable by PA (2.31 years). Females regain 2.96 years; males, 2.19 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.